HumanKine® recombinant human IL-28B protein HZ-1245 proteintech

$99.00
In stock
SKU
HZ-1245
Catalog No.SizePrice (USD)
HZ-1245-10UG10 μg$99.00
HZ-1245-50UG50 μg ( 5×10 μg )$332.00
HZ-1245-100UG100 μg$510.00
HZ-1245-500UG500 μg ( 5×100 μg )$1,658.00
HZ-1245-1000UG1000 μg$2,550.00
Purity>95%
FormulationUnited States
Formulation1x PBS, See Certificate of Analysis for details
Endotoxin<1 EU/μg
ReconstitutionBriefly centrifuge the vial before opening. It is recommended to reconstitute the protein to 0.2 mg/mL in sterile 1x PBS pH 7.4 containing 0.1% endotoxin-free recombinant human serum albumin (HSA). Gently swirl or tap vial to mix.
Host / IsotypeCytokine Zcyto22, IFN lambda 3, IFN lambda 4, IFNL3, IFNL4, IFN-lambda 3, IFN-lambda 4, IL 28B, IL 28C, IL28, IL-28, IL28B, IL-28B, IL28C, Interferon lambda 3, Interferon lambda 4, Interleukin 28B, Interleukin 28C, ZCYTO22
GeneID282617
ExpressionHEK293
Activity(Primary)0.07-0.35 ng/mL
Accession NumberQ8IZI9
Molecular Mass21 kDa reduced, 19 kDa non-reduced, monomer, non-glycosylated
Species Reactivityhuman
Stability and StorageProduct Form Temperature Conditions Storage Time (From Date of Receipt)
LyophilizedRoom Temperature 2 weeks
Reconstituted as per CofA4°C 1 week
humanFront Immunol MERS-CoV and SARS-CoV-1 proteins inhibit the IFN-α JAK/STAT pathway of epithelial cells, via IFN-λ-induced USP18. Authors - Yamei Zhang View Article

Publications

  1. Antiviral candidates against the hepatitis E virus (HEV) and their combinations inhibit HEV growth in in vitro.
    Journal: Antiviral Res | Authors: Takashi Nishiyama | Application: Antiviral Res Antiviral candidates against the hepatitis E virus (HEV) and their combinations inhibit HEV growth in in vitro. Authors - Takashi Nishiyama View Article
  2. IFN-λ3 as a host immune response in acute hepatitis E virus infection.
    Journal: Cytokine | Authors: Kazumoto Murata | Species: human | Application: Cytokine IFN-λ3 as a host immune response in acute hepatitis E virus infection. Authors - Kazumoto Murata View Article
  3. Screening of novel drugs for inhibiting hepatitis E virus replication.
    Journal: J Virol Methods | Authors: Takashi Nishiyama | Species: human | Application: J Virol Methods Screening of novel drugs for inhibiting hepatitis E virus replication. Authors - Takashi Nishiyama View Article
  4. MERS-CoV and SARS-CoV-1 proteins inhibit the IFN-α JAK/STAT pathway of epithelial cells, via IFN-λ-induced USP18.
    Journal: Front Immunol | Authors: Yamei Zhang | Species: human | Application: Front Immunol MERS-CoV and SARS-CoV-1 proteins inhibit the IFN-α JAK/STAT pathway of epithelial cells, via IFN-λ-induced USP18. Authors - Yamei Zhang View Article

Reviews

Write Your Own Review
You're reviewing:HumanKine® recombinant human IL-28B protein HZ-1245 proteintech
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.